Home › NDC Lookup › RxCUI directory › RxCUI 2673598

0.6 ML pegfilgrastim-cbqv 10 MG/ML Injection — RxCUI 2673598

Name: 0.6 ML pegfilgrastim-cbqv 10 MG/ML Injection (RxCUI 2673598)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2673598 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2673598

Official name0.6 ML pegfilgrastim-cbqv 10 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aspegfilgrastim-cbqv 6 MG per 0.6 ML On-body Injection; pegfilgrastim-cbqv 6 MG in 0.6 ML On-body Injection

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)13,009 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pegfilgrastim Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Chemotherapy works by targeting fast-growing cells — but that includes the cells in your bone marrow that make white blood cells. When white blood cell counts drop too low, your bo...
Why do I need this injection if I'm already getting chemotherapy?
It's given as a shot just under the skin — subcutaneously. Depending on the product and your situation, you might receive it via a manual prefilled syringe, or with the Neulasta on...
The most common side effects are bone pain and aching in your arms and legs — your bones are working harder to produce white blood cells, so some discomfort is normal. But call you...

📖 Read our full Pegfilgrastim Injection guide →

🕸️ Concept Web — How 0.6 ML pegfilgrastim-cbqv 10 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.6 ML pegfilgrastim-cbqv 10 MG/ML Injection RxCUI 2673598 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Pegfilgrastim 338036 IN
- Pegfilgrastim-cbqv 2102692 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Udenyca 2102695 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Pegfilgrastim Injection 2549330 SCDF
- Pegfilgrastim-cbqv Injection 2673597 SCDFP
- Pegfilgrastim Injectable Product 1161380 SCDG
- Pegfilgrastim-cbqv Injectable Product 2662139 SCDGP
- Pegfilgrastim Injection [Udenyca] 2673600 SBDF
- Pegfilgrastim-cbqv Injection [Udenyca] 2673601 SBDFP
- Udenyca Injectable Product 2102698 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Pegfilgrastim-cbqv 10 MG/ML 2102702 SCDC
- 0.6 ML pegfilgrastim-cbqv 10 MG/ML Injection [Udenyca] 2673602 SBD
- Pegfilgrastim-cbqv 10 MG/ML [Udenyca] 2102704 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Pegfilgrastim-cbqv 10 MG/ML SCDC · 2102702
Pegfilgrastim Injection SCDF · 2549330
Pegfilgrastim-cbqv Injection SCDFP · 2673597
Pegfilgrastim Injectable Product SCDG · 1161380
Pegfilgrastim-cbqv Injectable Product SCDGP · 2662139

Brand-Name Concepts

0.6 ML pegfilgrastim-cbqv 10 MG/ML Injection [Udenyca] SBD · 2673602
Pegfilgrastim-cbqv 10 MG/ML [Udenyca] SBDC · 2102704
Pegfilgrastim Injection [Udenyca] SBDF · 2673600
Pegfilgrastim-cbqv Injection [Udenyca] SBDFP · 2673601
Udenyca Injectable Product SBDG · 2102698
Udenyca BN · 2102695

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 2673598 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
69448-0025-63	1 SYRINGE in 1 CARTON (69448-025-63) / .6 mL in 1 SYRINGE	UDENYCA	Accord BioPharma, Inc.	2025-12-15
69448-0026-63	1 SYRINGE in 1 CARTON (69448-026-63) / .6 mL in 1 SYRINGE	UDENYCA	Accord BioPharma, Inc.	2026-03-23
69448-0027-63	1 SYRINGE in 1 CARTON (69448-027-63) / .6 mL in 1 SYRINGE	UDENYCA	Accord BioPharma, Inc.	2025-10-27
70114-0101-01	1 SYRINGE in 1 CARTON (70114-101-01) / .6 mL in 1 SYRINGE	UDENYCA	Coherus Oncology, Inc.	2018-11-02
70114-0120-01	1 SYRINGE in 1 CARTON (70114-120-01) / .6 mL in 1 SYRINGE	UDENYCA	Coherus Oncology, Inc.	2023-03-06
70114-0130-01	1 SYRINGE in 1 CARTON (70114-130-01) / .6 mL in 1 SYRINGE	UDENYCA	Coherus Oncology, Inc.	2023-12-22

Observed labelers: Accord BioPharma, Inc. (3) · Coherus Oncology, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
Q5111	Injection, udenyca 0.5 mg	5	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.